The Role of Training and Reminder Wristwatche in Hypertension

NCT05291000 | Completed DMC

• 1 other identifier: 83116987-662
• Study Type: interventional
• Target: 90
• Locations: 1 country
• Sites: 1

Brief Summary

This study is a randomized controlled study. The study was completed to with randomized selected 30 training and reminder by watch (experiment), 30 education (experiment) and 30 control group total of 90 hypertensive patients. Patients in the experimental group received training on hypertension and treatment adherence. In addition, the participants in the training and reminder by watch group wore a medication reminder wristwatch. Statistically significant differences were found in the post-test between scale scores of the experimental and control groups (p\<.05). It was observed that the initial blood pressure measurements were high in the patients in all three groups, while the highest decrease was found in the training and reminder by wristwatch group at the final measurement (p\<.05). Hypertension education program and using a medication reminder wristwatch were found to be effective in increasing treatment adherence.

Conditions

Hypertension; Adherence, Medication

Keywords

Elderly; Hypertension; Treatment Adherence; Training; Medication Reminder

Outcome Measures

Primary Outcomes (2)

• Antihypertensive Medication Treatment Adherence Scale (AMTAS)

  AMTAS is a questionnaire developed by Morisky et al to evaluate medication adherence of individuals with hypertensive in 2003. The scale includes 9 statements to diagnose the medication behavior and the total score varies between 1 and 13. Individuals with a score between 1 and 7 are defined as compliant with treatment, while individuals with a score of 8 and above are defined as non-compliant with treatment. The Turkish version of the AMTAS was validated by Demirezen et al. with Cronbach α = 0.82. In this study, the Cronbach's alpha of the scale was determined as 0.51.

  3 Month

• Medication Adherence Self-Efficacy Scale Short Form (MASES-SF)

  MASES-SF was developed in 2012 by Hacıhasanoğlu et al and include of 13 questions on a Likert scale. The total score of the scale is between 13 and 52, and an increase in the score indicates that the individual's level of compliance with antihypertensive drug treatment is good. The Cronbach's alpha was reported as 0.94. In this study, the Cronbach's alpha of the scale was found to be 0.83.

  3 Month

Study Arms (3)

RoT-ReWiH

EXPERIMENTAL

First, pre-tests were applied to the patients in the training and reminder by watch group at first home visit.Second home visits were conducted participants 12th weeks after the first home visit.One of the researchers presented the education program to individuals with hypertensive.The education program included issues related to hypertension, measurament of pressure blood, lifestyle changes and adherence to treatment. The program using face-to-face communication technique and lasted about 45 minutes.For the patients in this group, the alarm time was set according to the time when blood pressure medication was taken, the cord was adjusted according to the arm, and then information was given about the use of the watch. At the end of the interview, the blood pressure of the experimental groups was measured and the measurement value was recorded on the blood pressure follow-up card.

Behavioral: The Role of Training and Reminder Wristwatche in Hypertension (RoT-ReWiH)

Training group

EXPERIMENTAL

First, pre-tests were applied to the patients in the training group at first home visit.The education program included issues related to hypertension, measurament of pressure blood, lifestyle changes and adherence to treatment. The program using face-to-face communication technique and lasted about 45 minutes. In addition, other drugs used by individuals at home (such as painkillers, antibiotics) were also evaluated during the home visit, and a red label was made on the antihypertensive drug box to distinguish antihypertensive drugs from other drugs. At the end of the interview, the blood pressure of the experimental groups was measured and the measurement value was recorded on the blood pressure follow-up card.

Behavioral: The Role of Training and Reminder Wristwatche in Hypertension (RoT-ReWiH)

Control group

NO INTERVENTION

Pre-tests was applied to the patients in the control group.No intervention was be applied to the patients in this group and second home visit 12th weeks after the first home visit and were readministered the post-tests.

Interventions

The Role of Training and Reminder Wristwatche in Hypertension (RoT-ReWiH) BEHAVIORAL

The present study revealed that multiple interventions such as home visits to elderly hypertensive patients, training program, telephone counseling, and the use of medication reminder wristwatch are effective in increasing treatment adherence and self-efficacy, and in controlling blood pressure. In this direction, health professionals working in primary care are recommended that they make regular home visits, encourage patients to take responsibility for health, and organize regular and interdisciplinary training and counseling programs in the management of hypertension.

RoT-ReWiH; Training group

Eligibility Criteria

• Age: 65 Years - 92 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)

You may qualify if:

• The patients who were 65 and older, who were diagnosed with hypertension, who used at least one antihypertensive drug, who are literate and open to communication and cooperation, who had blood pressure of 140/90mmHg or above prior to the research, who had a score of 8 and above from the Compliance with Drug Therapy Scale, and who were willing to participate were included in the study.

You may not qualify if:

• Being diagnosed with malignancy
• İlliteracy
• Having a history of cardiac intervention in the past year
• Hearing-vision loss

Sponsors & Collaborators

• Ondokuz Mayıs University: lead

Study Sites (1)

Erbaa Family Health Center

Tokat Province, Erbaa, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypertension; Medication Adherence; Treatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases; Patient Compliance; Patient Acceptance of Health Care; Health Behavior; Behavior

Study Officials

• Birsen ALTAY, Doç. Dr.

  Ondokuz Mayıs University

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head of Nursing Department

Model Details: Randomized controlled experimental design

Study Record Dates

• First Submitted: March 14, 2022
• First Posted: March 22, 2022
• Study Start: April 1, 2019
• Primary Completion: November 30, 2020
• Study Completion: December 31, 2020
• Last Updated: March 22, 2022

Record last verified: 2022-03

Locations

TU (1)